CDXS - CIK 0001200375
CODEXIS, INC. trades as CDXS. In its fiscal 2025 annual report the company posted revenue of $70.39M, up 18.6% from the prior year and net income of -$43.97M. This page tracks CODEXIS, INC. through 989 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years CODEXIS, INC.'s revenue grew from $48.84M to $70.39M, a compound annual growth rate of 4.1%. Net profit margin compressed from -17.5% to -62.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-05-05 |
| Annual report to shareholders | ARS | 2026-04-28 |
| Proxy materials | DEFA14A | 2026-04-28 |
| Proxy statement | DEF 14A | 2026-04-28 |
| Major company event | 8-K | 2026-04-14 |
| SCHEDULE 13G | - | 2026-04-14 |
The largest companies sharing CODEXIS, INC.'s SEC industry classification (industrial organic chemicals).
CODEXIS, INC. reported revenue of $70.39M for fiscal year 2025, an increase of 18.6% year over year.
In its latest fiscal year CODEXIS, INC. reported a net loss of $43.97M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.